Pregabalin Completed Phase 3 Trials for Peripheral Neuropathic Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02985216Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain